Updated:
Pharmascience
Pharmascience began operations in 1983, founded by pharmacists who aimed to serve other pharmacists and their patients.
Pharmascience
Pharmascience began operations in 1983, founded by pharmacists who aimed to serve other pharmacists and their patients. The company remains privately held; its ownership structure and wealth origin are not publicly disclosed beyond the founding professional background. The company focuses on generic pharmaceuticals, specialty medicines, and contract manufacturing. Pharmascience manufactures a broad portfolio of generic drugs at its Montreal facility and distributes them in over 50 countries. Through its Pendopharm division, it develops and markets single-source specialty drugs in gastroenterology, orthopedics, and neurology. The firm commits approximately $65 million per year to Canadian R&D (per firm website, 2025). Pharmascience maintains its headquarters in Montreal and has an additional office in New York. The company does not publicly disclose total employees, AUM, or deployment figures. No named executives, investment professionals, or philanthropic vehicles are detailed on its public-facing site. As a private commercial entity, Pharmascience does not operate a family office or investment vehicle visible in public records. Pharmascience's structural differentiator is its integrated Canadian production base and its unusual degree of R&D localization — all research spending remains in Canada. The company is not an investment manager; it is a privately held operating company in the pharmaceutical sector. Its profile as a family-office-relevant entity rests on the undisclosed wealth its founding family has generated from the business.
General information
Firm type
other
Year founded
1983
AUM
Undisclosed
Location
Region
North America
Country
Canada
City
Montreal
Corporate office
Montreal, Quebec, Canada
Additional offices
New York, United States
Sector focus
Frequently asked questions
Who owns Pharmascience?
Pharmascience is a privately held company; its ownership is not publicly attributed to specific individuals or families. The firm was founded by a group of pharmacists and remains closely held.
Does Pharmascience operate as a family office or investment vehicle?
No. Pharmascience is an operating pharmaceutical company, not a family office. It manufactures and distributes generic and specialty drugs. Any family wealth generated from the business is managed separately and not disclosed.
What is Pharmascience's investment in R&D?
The company states it spends roughly $65 million per year on research and development, all of which is kept in Canada (per firm website, 2025). This supports its generic portfolio and Pendopharm specialty pipeline.
Is Pendopharm a separate company?
Pendopharm is a division of Pharmascience, not a separate entity. It focuses on single-source specialty drugs in gastroenterology, orthopedics, and neurology for the Canadian market.
Where does Pharmascience manufacture its products?
Pharmascience manufactures at its own facility in Montreal, Canada. This domestic production base allows the company to claim a reliable supply chain.
In how many countries does Pharmascience distribute?
Pharmascience distributes its products in over 50 countries through local distribution and commercial partnerships (per firm website, 2025).
How does Pharmascience's scale compare in the Canadian generic market?
Pharmascience claims to be the leading Canadian generic drug manufacturer by domestic market share, a position built through rapid market-share growth since its founding in 1983 (per firm website, 2025).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: